{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:20:45Z","timestamp":1790972445092,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,8,1]]},"DOI":"10.1038\/sj.leu.2401845","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:36:40Z","timestamp":1031164600000},"page":"1405-1413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine"],"prefix":"10.1038","volume":"14","author":[{"given":"P","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Van Den Neste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Plunkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,8,4]]},"reference":[{"key":"BF2401845_CR1","first-page":"11","volume":"25","author":"JC Reed","year":"1998","unstructured":"Reed JC . Molecular biology of chronic lymphocytic leukemia Semin Oncol 1998 25: 11\u201318","journal-title":"Semin Oncol"},{"key":"BF2401845_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00062752-199704040-00008","volume":"4","author":"J Kipps T","year":"1997","unstructured":"Kipps T J . Chronic lymphocytic leukemia Curr Opin Hematol 1997 4: 268\u2013276","journal-title":"Curr Opin Hematol"},{"key":"BF2401845_CR3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V92.4.1165","volume":"92","author":"MJ Keating","year":"1998","unstructured":"Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, Kantarjian H . Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy Blood 1998 92: 1165\u20131171","journal-title":"Blood"},{"key":"BF2401845_CR4","first-page":"83","volume":"38","author":"J Keating M","year":"1996","unstructured":"Keating M J, O'Brien S, McLaughlin P, Dimopoulos M, Gandhi V, Plunkett W, Lerner S, Kantarjian H, Estey E . Clinical experience with fludarabine in hemato-oncology Hematol Cell Ther 1996 38: (Suppl. 2) 83\u201391","journal-title":"Hematol Cell Ther"},{"key":"BF2401845_CR5","first-page":"1005","volume":"53","author":"JC Adkins","year":"1997","unstructured":"Adkins JC, Peters DH, Markham A . Fludarabine: an update of its pharmacology and use in the treatment of haematological malignancies Drugs 1997 53: 1005\u20131037","journal-title":"Drugs"},{"key":"BF2401845_CR6","first-page":"28","volume":"31","author":"MJ Keating","year":"1994","unstructured":"Keating MJ, O'Brien S, Plunkett W, Robertson LE, Gandhi V, Estey E, Dimopoulos M, Cabanillas F, Kemena A, Kantarjian H . Fludarabine phosphate: a new active agent in hematologic malignancies Semin Hematol 1994 31: 28\u201339","journal-title":"Semin Hematol"},{"key":"BF2401845_CR7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/sj.leu.2400816","volume":"11","author":"S O'Brien","year":"1997","unstructured":"O'Brien S, Kantarjian H, Beran M, Koller C, Talpaz M, Lerner S, Keating MJ . Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia Leukemia 1997 11: 1631\u20131635","journal-title":"Leukemia"},{"key":"BF2401845_CR8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1200\/JCO.1997.15.2.458","volume":"15","author":"JM Sorensen","year":"1997","unstructured":"Sorensen JM, Vena DA, Fallavollita A, Chun HG, Cheson BD . Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report J Clin Oncol 1997 15: 458\u2013465","journal-title":"J Clin Oncol"},{"key":"BF2401845_CR9","doi-asserted-by":"crossref","first-page":"16617","DOI":"10.1016\/S0021-9258(17)46267-3","volume":"265","author":"P Huang","year":"1990","unstructured":"Huang P, Chubb S, Plunkett W . Termination of DNA synthesis by 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine: a mechanism for cytotoxicity J Biol Chem 1990 265: 16617\u201316625","journal-title":"J Biol Chem"},{"key":"BF2401845_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00685844","volume":"36","author":"P Huang","year":"1995","unstructured":"Huang P, Plunkett W . Fludarabine and gemcitabine-induced apoptosis: Incorporation of analogs into DNA is a critical event Cancer Chemother Pharmacol 1995 36: 181\u2013188","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF2401845_CR11","first-page":"1005","volume":"1","author":"P Huang","year":"1995","unstructured":"Huang P, Robertson LE, Wright S, Plunkett W . High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells Clin Cancer Res 1995 1: 1005\u20131013","journal-title":"Clin Cancer Res"},{"key":"BF2401845_CR12","first-page":"3407","volume":"57","author":"P Huang","year":"1997","unstructured":"Huang P, Ballal K, Plunkett W . Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis Cancer Res 1997 57: 3407\u20133414","journal-title":"Cancer Res"},{"key":"BF2401845_CR13","first-page":"485","volume":"34","author":"WB Parker","year":"1988","unstructured":"Parker WB, Bapat AR, Shen JX, Townsend AJ, Cheng YC . Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase Mol Pharmacol 1988 34: 485\u2013491","journal-title":"Mol Pharmacol"},{"key":"BF2401845_CR14","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1016\/S0021-9258(18)53162-8","volume":"268","author":"CV Catapano","year":"1993","unstructured":"Catapano CV, Perrino FW, Fernandes DJ . Primer RNA chain termination induced by 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine 5\u2032-triphosphate: a mechanism of DNA synthesis inhibition J Biol Chem 1993 268: 7179\u20137185","journal-title":"J Biol Chem"},{"key":"BF2401845_CR15","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0021-9258(18)45884-X","volume":"267","author":"SW Yang","year":"1992","unstructured":"Yang SW, Huang P, Plunkett W, Becker FF, Chan JYH . Dual mode of inhibition of purified DNA ligase I from human cells by 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine triphosphate J Biol Chem 1992 267: 2345\u20132349","journal-title":"J Biol Chem"},{"key":"BF2401845_CR16","first-page":"449","volume":"39","author":"P Huang","year":"1991","unstructured":"Huang P, Plunkett W . Action of 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism Mol Pharmacol 1991 39: 449\u2013455","journal-title":"Mol Pharmacol"},{"key":"BF2401845_CR17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-113-7-525","volume":"113","author":"KA Foon","year":"1990","unstructured":"Foon KA, Rai KR, Gale RP . Chronic lymphocytic leukemia: new insights into biology and therapy Ann Intern Med 1990 113: 525\u2013539","journal-title":"Ann Intern Med"},{"key":"BF2401845_CR18","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.1994.12.9.1974","volume":"12","author":"GB Faguet","year":"1994","unstructured":"Faguet GB . Chronic lymphocytic leukemia: an updated review J Clin Oncol 1994 12: 1974\u20131990","journal-title":"J Clin Oncol"},{"key":"BF2401845_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830290307","volume":"29","author":"BD Cheson","year":"1988","unstructured":"Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ, Foon KA . Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group Am J Hematol 1988 29: 152\u2013163","journal-title":"Am J Hematol"},{"key":"BF2401845_CR20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1074\/jbc.270.2.631","volume":"270","author":"Y-Z Xu","year":"1995","unstructured":"Xu Y-Z, Huang P, Plunkett W . Functional compartmentation of dCTP pools: preferential utilization of salvaged deoxycytidine for DNA repair in human lymphoblasts J Biol Chem 1995 270: 631\u2013637","journal-title":"J Biol Chem"},{"key":"BF2401845_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V90.1.270.270_270_278","volume":"90","author":"H Iwasaki","year":"1997","unstructured":"Iwasaki H, Huang P, Keating MJ, Plunkett W . Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells Blood 1997 90: 270\u2013278","journal-title":"Blood"},{"key":"BF2401845_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V81.1.143.143","volume":"81","author":"LE Robertson","year":"1993","unstructured":"Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W . Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2\u2032-deoxyadenosine and 9-\u03b2-D-arabinosyl-2-fluoroadenine Blood 1993 81: 143\u2013150","journal-title":"Blood"},{"key":"BF2401845_CR23","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/0006-2952(94)90600-9","volume":"48","author":"JM Cherrington","year":"1994","unstructured":"Cherrington JM, Allen SJ, McKee BH, Chen MS . Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma Biochem Pharmacol 1994 48: 1986\u20131988","journal-title":"Biochem Pharmacol"},{"key":"BF2401845_CR24","first-page":"110","volume":"57","author":"K Bouayadi","year":"1997","unstructured":"Bouayadi K, Hoffmann JS, Fons P, Tiraby M, Reynes JP, Cazaux C . Overexpression of DNA polymerase beta sensitizes mammalian cells to 2\u2032,3\u2032-deoxycytidine and 3\u2032-azido-3\u2032-deoxythymidine Cancer Res 1997 57: 110\u2013116","journal-title":"Cancer Res"},{"key":"BF2401845_CR25","first-page":"6110","volume":"51","author":"P Huang","year":"1991","unstructured":"Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W . Action of 2\u2032,2\u2032-difluorodeoxycytidine on DNA synthesis Cancer Res 1991 51: 6110\u20136117","journal-title":"Cancer Res"},{"key":"BF2401845_CR26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0014-5793(83)80950-8","volume":"160","author":"VA Aivasashvilli","year":"1983","unstructured":"Aivasashvilli VA, Beabealashvilli RS . Sequence-specific inhibition of RNA elongation by actinomycin D FEBS Lett 1983 160: 124\u2013128","journal-title":"FEBS Lett"},{"key":"BF2401845_CR27","first-page":"1487","volume":"57","author":"L Li","year":"1997","unstructured":"Li L, Liu X, Glassman AB, Keating MJ, Plunkett W, Yang LY . Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro Cancer Res 1997 57: 1487\u20131494","journal-title":"Cancer Res"},{"key":"BF2401845_CR28","first-page":"1731","volume":"2","author":"A Sandoval","year":"1996","unstructured":"Sandoval A, Consoli U, Plunkett W . Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes Clin Cancer Res 1996 2: 1731\u20131741","journal-title":"Clin Cancer Res"},{"key":"BF2401845_CR29","first-page":"1072","volume":"47","author":"LY Yang","year":"1995","unstructured":"Yang LY, Li L, Keating MJ, Plunkett W . Arabinosylfluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair Mol Pharmacol 1995 47: 1072\u20131079","journal-title":"Mol Pharmacol"},{"key":"BF2401845_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-2952(86)90521-6","volume":"35","author":"D Spriggs","year":"1986","unstructured":"Spriggs D, Robbins G, Mitchell T, Kufe D . Incorporation of 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA Biochem Pharmacol 1986 35: 247\u2013252","journal-title":"Biochem Pharmacol"},{"key":"BF2401845_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1074\/jbc.275.1.29","volume":"275","author":"D Genini","year":"2000","unstructured":"Genini D, Budihardjo I, Plunkett W, Wang X, Carrera CJ, Cottam HB, Carson DA, Leoni LM . Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway J Biol Chem 2000 275: 29\u201334","journal-title":"J Biol Chem"},{"key":"BF2401845_CR32","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1182\/blood.V84.10.3440.3440","volume":"84","author":"R Silber","year":"1994","unstructured":"Silber R, Degar B, Costin D, Newcomb EW, Mani M, Rosenberg CR, Morse L, Drygas JC, Canellakis ZN, Potmesil M . Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs Blood 1994 84: 3440\u20133446","journal-title":"Blood"},{"key":"BF2401845_CR33","first-page":"1055","volume":"12","author":"A Thomas","year":"1996","unstructured":"Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M, Newcomb EW . Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2\/bax proteins in drug resistance Oncogene 1996 12: 1055\u20131062","journal-title":"Oncogene"},{"key":"BF2401845_CR34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-120-9-199405010-00010","volume":"120","author":"A Saven","year":"1994","unstructured":"Saven A, Piro LD . 2-Chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancies Ann Intern Med 1994 120: 784\u2013791","journal-title":"Ann Intern Med"},{"key":"BF2401845_CR35","first-page":"6923","volume":"49","author":"J Griffig","year":"1989","unstructured":"Griffig J, Koob R, Blakley RL . Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells Cancer Res 1989 49: 6923\u20136928","journal-title":"Cancer Res"},{"key":"BF2401845_CR36","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1016\/S0021-9258(19)39698-X","volume":"265","author":"P Hentosh","year":"1990","unstructured":"Hentosh P, Koob R, Blakley RL . Incorporation of 2-halogeno-2\u2032-deoxyadenosine 5-triphosphates into DNA during replication by human polymerases alpha and beta J Biol Chem 1990 265: 4033\u20134040","journal-title":"J Biol Chem"},{"key":"BF2401845_CR37","first-page":"897","volume":"48","author":"P Hentosh","year":"1995","unstructured":"Hentosh P, Tibudan M . In vitro transcription of DNA containing 2-chloro-2\u2032-deoxyadenosine monophosphate Mol Pharmacol 1995 48: 897\u2013904","journal-title":"Mol Pharmacol"},{"key":"BF2401845_CR38","first-page":"469","volume":"39","author":"MM Bartik","year":"1998","unstructured":"Bartik MM, Kay NE . Inhibition of IL-2 production mediates fludarabine-induced suppression of normal human T cell activation leading to apoptosis Proc Am Assoc Cancer Res 1998 39: 469","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF2401845_CR39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/bjc.1991.341","volume":"64","author":"RJ Collins","year":"1991","unstructured":"Collins RJ, Harmon BV, Souvlis T, Pope JH, Kerr JF . Effect of cycloheximide on B-chronic lymphocytic leukemic and normal lymphocytes in vitro: induction of apoptosis Br J Cancer 1991 64: 518\u2013522","journal-title":"Br J Cancer"},{"key":"BF2401845_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archinte.1955.04430010075008","volume":"115","author":"JC Wright","year":"1955","unstructured":"Wright JC, Dolgopol VB, Logan M, Prigot A, Wright L . Clinical evaluation of puromycin in human neoplastic disease AMA Arch Intern Med 1955 115: 61\u201377","journal-title":"AMA Arch Intern Med"},{"key":"BF2401845_CR41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V92.3.990","volume":"92","author":"MF Romano","year":"1998","unstructured":"Romano MF, Lamberti A, Tassone P, Alfinito F, Costantini S, Chiurazzi F, Defrance T, Bonelli P, Tuccillo F, Turco MC, Venuta S . Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells Blood 1998 92: 990\u2013995","journal-title":"Blood"},{"key":"BF2401845_CR42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.1999.01642.x","volume":"106","author":"S Kitada","year":"1999","unstructured":"Kitada S, Zapata JM, Andreeff M, Reed JC . Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia Br J Haematol 1999 106: 995\u20131004","journal-title":"Br J Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401845","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:54:16Z","timestamp":1648760056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,1]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8,1]]}},"alternative-id":["BF2401845"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401845","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,1]]},"assertion":[{"value":"16 March 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}